Correlation Between AN2 Therapeutics and Rhythm Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Rhythm Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Rhythm Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Rhythm Pharmaceuticals, you can compare the effects of market volatilities on AN2 Therapeutics and Rhythm Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Rhythm Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Rhythm Pharmaceuticals.
Diversification Opportunities for AN2 Therapeutics and Rhythm Pharmaceuticals
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between AN2 and Rhythm is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Rhythm Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rhythm Pharmaceuticals and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Rhythm Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rhythm Pharmaceuticals has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Rhythm Pharmaceuticals go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Rhythm Pharmaceuticals
Given the investment horizon of 90 days AN2 Therapeutics is expected to under-perform the Rhythm Pharmaceuticals. In addition to that, AN2 Therapeutics is 1.83 times more volatile than Rhythm Pharmaceuticals. It trades about -0.01 of its total potential returns per unit of risk. Rhythm Pharmaceuticals is currently generating about 0.11 per unit of volatility. If you would invest 1,769 in Rhythm Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of 4,435 from holding Rhythm Pharmaceuticals or generate 250.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AN2 Therapeutics vs. Rhythm Pharmaceuticals
Performance |
| Timeline |
| AN2 Therapeutics |
| Rhythm Pharmaceuticals |
AN2 Therapeutics and Rhythm Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AN2 Therapeutics and Rhythm Pharmaceuticals
The main advantage of trading using opposite AN2 Therapeutics and Rhythm Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Rhythm Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rhythm Pharmaceuticals will offset losses from the drop in Rhythm Pharmaceuticals' long position.| AN2 Therapeutics vs. Tff Pharmaceuticals | AN2 Therapeutics vs. Eliem Therapeutics | AN2 Therapeutics vs. Inhibrx | AN2 Therapeutics vs. Enliven Therapeutics |
| Rhythm Pharmaceuticals vs. Revolution Medicines | Rhythm Pharmaceuticals vs. Akero Therapeutics | Rhythm Pharmaceuticals vs. Avidity Biosciences | Rhythm Pharmaceuticals vs. Protagonist Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |